Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana

Plain-language summary

This study investigates how genetic differences between people (pharmacogenetic variation) may affect the efficacy and safety of medical marijuana. People aged 18 and older who obtain medical marijuana products from Columbia Care and consent to DNA analysis could take part. It was carried out as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Columbia Care Inc.

Intervention

DNA Genotek Oragene 600

Start date

7/11/2019

Estimated completion

3/30/2020

Countries

United States

Related genes

Locations

• New York, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Males and Females age 18 and older
* Currently obtaining medical marijuana products from Columbia Care LLC
* Willing to participate and consent to a DNA analysis
* Purchased product from Columbia Care for three consecutive encounters spanning a 6-month period

Exclusion Criteria:

* Unwillingness to participate and consent to a DNA analysis
* Unwillingness to answer a survey/questionnaire on patient satisfaction as related to product efficacy